Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Amgen AMGN will report third-quarter 2025 results on Nov. 4, before market open. In the last reported quarter, the company's earnings beat expectations by 14.5%. The Zacks Consensus Estimate for third ...

Amgen (NASDAQ:AMGN) is preparing to release its quarterly earnings on Tuesday, 2026-02-03. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect Amgen ...

Pfizer and Amgen both grew revenue last quarter at nearly the same pace, but the engines driving that growth point toward two very different futures in oncology. One company is collecting cash from ...

Amgen (AMGN) came out with quarterly earnings of $5.29 per share, beating the Zacks Consensus Estimate of $4.76 per share. This compares to earnings of $5.31 per share a year ago. These figures are ...

In the latest trading session, Amgen (AMGN) closed at $355.25, marking a -1.44% move from the previous day. The stock's ...

Amgen Inc () has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium. Unlock hedge fund-level data and powerful investing tools ...

Amgen’s (AMGN) fourth-quarter earnings on Tuesday will have investors looking out for developments around the company’s obesity drug candidate MariTide. Earlier this month, UBS upgraded Amgen to Buy ...

Amgen Inc () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smar ...